Merck to buy Harrisvaccines to boost livestock vaccine portfolio
November 12, 2015 at 19:46 PM EST
CHICAGO, Nov 12 (Reuters) - Merck & Co Inc's animal health unit will buy privately held Harrisvaccines Inc to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against diseases, the companies said on Thursday.
